OVERVIEW

Mod GRF and Ipamorelin 10mg (blend) is a combination of two growth hormone–stimulating peptides often discussed in research and performance settings. Mod GRF, also known as CJC-1295 without DAC, is a modified version of growth hormone–releasing hormone (GHRH) that supports the body’s natural, pulsatile release of growth hormone from the pituitary gland. Ipamorelin is a selective growth hormone–releasing peptide (GHRP) that mimics the action of ghrelin while producing minimal impact on cortisol and prolactin levels compared to some other GHRPs. When combined in a 10mg blend, these peptides are believed to work synergistically to enhance endogenous growth hormone secretion in a more physiologic pattern.

This blend is commonly explored for its potential to support muscle recovery, lean muscle development, improved sleep quality, and enhanced fat metabolism. By encouraging the body’s own growth hormone production rather than supplying synthetic hormone directly, it may promote gradual and balanced effects. However, Mod GRF and Ipamorelin are not approved by major regulatory authorities for general medical or cosmetic use and are typically marketed for research purposes only. Possible side effects may include mild water retention, headache, increased appetite, or temporary flushing. Because these compounds influence hormonal pathways, consultation with a qualified healthcare professional is strongly advised before considering use.